Skip to main content
  • Long-Term Outcome of Endovascular Embolization of Complex Intracranial Aneurysms with Onyx: Experience from a Single Tertiary Center

    Final Number:
    339

    Authors:
    Leonardo Rangel-Castilla MD; Yi Jonathan Zhang MD; Sean Barber MD; Richard Klucznik MD; Diaz M Orlando MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: We present the largest US case series with long-term follow-up using Onyx in the endovascular management of complex intracranial aneurysms with high rate of incomplete occlusion and recanalization.

    Methods: Nineteen patients with 21 complex intracranial aneurysms were treated. Fifteen aneurysms were in the anterior circulation (7 ophthalmic sidewall, 5 cavernous ICA, 1 petrous ICA, 1 superior hypophyseal and 1 MCA). Six were in the posterior circulation (4 PICA, 1 vertebral, 1 basilar). Four presented with SAH. All were complex aneurysms (e.g. wide-neck, large or giant, fusiform, dissecting-type, or associated to an AVM). Four were treated in the past with other materials. Onyx HD-500 was used in 17 aneurysms, Onyx 34 and 18 in 2 patients each. Coils and stents were used in 5 and 4 patients respectively. Embolization of the feeding vessel was necessary in 2 patients. Clinical and angiographic follow-up was obtained at 2.6 years (6 months – 10 years) and 1.3 years (6 months -5 years), respectively.

    Results: Twenty aneurysms were completely occluded on immediate post-embolization angiogram, 1 had a small residual neck. Onyx migration was observed in 4 aneurysms with no radiographic or clinical consequences. Angiographic follow-up showed recanalization in 1 large aneurysm requiring additional Onyx obliteration of the parent vessel. No peri-procedural mortality was observed. Two patients with cavernous ICA aneurysm had a transient third nerve palsy after embolization. Two patients with SAH died of disease-relate complications.

    Conclusions: Onyx embolization of complex intracranial aneurysms is feasible, safe and effective. Onyx is a good option in the management of aneurysms recurrences, fusiform and dissecting-type aneurysms. Morbidity and mortality rates are similar to other endovascular techniques. Onyx provides durable aneurysm occlusion at mid- and long-term follow-up.

    Patient Care: Patients with aneurysm recurrence and complex intracranial aneurysms have another alternative of endovascular embolization other than platinium coils. Onyx is a good alternative with durable and stable oblitaration rate at long-term follow-up.

    Learning Objectives: Describe the importance of the liquid embolic agent Onyx as alternative of the endovascular embolization of complex intracranial aneurysms.

    References: Cekirge HS, Saatci I, Ozturk MH, Cil B, Arat A, Mawad M, Ergungor F, Belen D, Er U, Turk S, Bavbek M, Sekerci Z, Beskonakli E, Ozcan OE, Ozgen T: Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience. Neuroradiology 48:113-126, 2006. Dalyai RT, Randazzo C, Ghobrial G, Gonzalez LF, Tjoumakaris SI, Dumont AS, Rosenwasser RH, Jabbour P: Redefining Onyx HD 500 in the Flow Diversion Era. Int J Vasc Med 2012:435490, 2012. Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med 339:1725-1733, 1998. Mawad ME, Cekirge S, Ciceri E, Saatci I: Endovascular treatment of giant and large intracranial aneurysms by using a combination of stent placement and liquid polymer injection. Journal of neurosurgery 96:474-482, 2002. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 360:1267-1274, 2002. Molyneux AJ, Cekirge S, Saatci I, Gal G: Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR American journal of neuroradiology 25:39-51, 2004.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy